Cadence Capital Management’s Clorox CLX Stock Holding History

Cadence Capital Management’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$667K	Sell	3,175 -867	-21%	-$193K	0.16%	105
2020 Q2	$887K	Buy	4,042 +1,026	+34%	+$205K	0.13%	243
2020 Q1	$523K	Sell	3,016 -2,085	-41%	-$344K	0.09%	312
2019 Q4	$783K	Sell	5,101 -101	-2%	-$15.1K	0.08%	306
2019 Q3	$790K	Sell	5,202 -1,824	-26%	-$288K	0.11%	289
2019 Q2	$1.08M	Sell	7,026 -1,219	-15%	-$186K	0.11%	261
2019 Q1	$1.32M	Sell	8,245 -44	-0.5%	-$6.83K	0.12%	233
2018 Q4	$1.28M	Sell	8,289 -10,209	-55%	-$1.59M	0.13%	230
2018 Q3	$2.78M	Buy	18,498 +517	+3%	+$73.4K	0.15%	177
2018 Q2	$2.43M	Buy	17,981 +185	+1%	+$22.8K	0.14%	182
2018 Q1	$2.37M	Sell	17,796 -1,648	-8%	-$221K	0.15%	157
2017 Q4	$2.89M	Sell	19,444 -1,065	-5%	-$145K	0.18%	118
2017 Q3	$2.71M	Sell	20,509 -4,588	-18%	-$616K	0.17%	130
2017 Q2	$3.34M	Sell	25,097 -586	-2%	-$79.1K	0.23%	109
2017 Q1	$3.46M	Sell	25,683 -6,500	-20%	-$842K	0.24%	102
2016 Q4	$3.86M	Buy	32,183 +2,704	+9%	+$319K	0.27%	90
2016 Q3	$3.69M	Sell	29,479 -7,608	-21%	-$996K	0.27%	97
2016 Q2	$5.13M	Buy	37,087 +18,393	+98%	+$2.38M	0.39%	69
2016 Q1	$2.36M	Sell	18,694 -16,870	-47%	-$2.14M	0.17%	151
2015 Q4	$4.51M	Buy	35,564 +10,207	+40%	+$1.27M	0.3%	85
2015 Q3	$2.93M	Sell	25,357 -7,220	-22%	-$811K	0.21%	126
2015 Q2	$3.39M	Buy	32,577 +15,434	+90%	+$1.67M	0.19%	143
2015 Q1	$1.89M	Sell	17,143 -3,432	-17%	-$373K	0.12%	238
2014 Q4	$2.14M	Sell	20,575 -9,620	-32%	-$962K	0.12%	214
2014 Q3	$2.9M	Buy	30,195 +4,744	+19%	+$429K	0.15%	180
2014 Q2	$2.33M	Sell	25,451 -6,008	-19%	-$538K	0.11%	295
2014 Q1	$2.77M	Sell	31,459 -6,054	-16%	-$531K	0.12%	295
2013 Q4	$3.48M	Sell	37,513 -2,554	-6%	-$230K	0.13%	289
2013 Q3	$3.27M	Buy	+40,067	New	+$3.38M	0.11%	303

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cadence Capital Management's CLX Position: Q3 2020 in Review

Cadence Capital Management reduced its Clorox (CLX) stake by 21% in Q3 2020, selling an estimated $193K and leaving 3,175 shares worth $667K. The position accounts for 0.16% of the portfolio, ranked #105.

Cadence Capital Management first reported a position in CLX in Q3 2013 and has held it in 29 quarters since. The position peaked at $5.13M in Q2 2016. 1,202 funds tracked by Wall St. Rank hold CLX as of Q3 2020.

Cadence Capital Management held 3,175 shares of Clorox worth $667K as of Q3 2020.
Cadence Capital Management sold 867 Clorox shares in Q3 2020, an estimated $193K.
Clorox made up 0.16% of Cadence Capital Management's portfolio in Q3 2020, its #105 holding.
Cadence Capital Management first reported a position in Clorox in Q3 2013 and has held it in 29 quarters since.
Cadence Capital Management's Clorox position peaked at $5.13M in Q2 2016.
1,202 funds tracked by Wall St. Rank held Clorox as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.